Search Results - Kumar, Dhiren
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients by Song, Chelsey Chenxi, Brown, Andrew, Winstead, Ryan, Yakubu, Idris, Demehin, Moses, Kumar, Dhiren, Gupta, Gaurav
Published 2020Text -
6
-
7
Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation by Pai, Akshta, Swan, Joshua T., Wojciechowski, David, Qazi, Yasir, Dholakia, Sham, Shekhtman, Grigoriy, Abou-Ismail, Anas, Kumar, Dhiren
Published 2021Text -
8
-
9
Coronavirus Disease 2019 Viremia, Serologies, and Clinical Course in a Case Series of Transplant Recipients by Christensen, Johanna, Kumar, Dhiren, Moinuddin, Irfan, Bryson, Alexandra, Kashi, Zahra, Kimball, Pamela, Levy, Marlon, Kamal, Layla, King, Anne, Gupta, Gaurav
Published 2020Text -
10
Lack of Histological and Molecular Signature Response to Tocilizumab in Kidney Transplants with Chronic Active Antibody Mediated Rejection: A Case Series by Kumar, Dhiren, Yakubu, Idris, Safavi, Frough, Levy, Marlon, Moinuddin, Irfan, Kimball, Pamela, Kamal, Layla, King, Anne, Massey, Davis, Halloran, Philip, Gupta, Gaurav
Published 2020Text -
11
High levels of dd‐cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury by Stites, Erik, Kumar, Dhiren, Olaitan, Oyedolamu, John Swanson, Sidney, Leca, Nicolae, Weir, Matthew, Bromberg, Jonathan, Melancon, Joseph, Agha, Irfan, Fattah, Hasan, Alhamad, Tarek, Qazi, Yasir, Wiseman, Alexander, Gupta, Gaurav
Published 2020Text